IFN‐γ Gene Therapy by Intrasplenic Hepatocyte Transplantation: a Novel Strategy for Reversing Hepatic Fibrosis in Schistosoma Japonicum‐infected Mice

LH Zhang,J Mi,YZ Yu,HP Yao,H Chen,MW Li,XT Cao

DOI: https://doi.org/10.1046/j.1365-3024.2001.00349.x

2001-01-01

Parasite Immunology

Abstract:Liver‐targeted gene therapy using hepatocyte as recipient cells has recently been documented to be effective in treatment of numerous hepatic diseases, such as metabolic diseases and liver carcinoma. IFN‐γ elicits antipreliferative and antifibrogenic activity in a variety of mesenchymal cells, including hepatic satellite cells. To investigate the antifibrogenic response of liver gene therapy mediated by intrasplenic transplantation of gene‐modified hepatocytes, normal mouse liver cell line BNL CL.2 cells were transfected with murine IFN‐γ gene (BNL.IFN‐γ) in vitro, and transplanted intrasplenically into Schistosoma japonicum‐infected mice. The amounts and distribution of IFN‐γ (which inhibits collagen synthesis), TGF‐β (which stimulates collagen synthesis) and extracellular matrix, including type I and III collagen, were detected. In mice infected with S. japonicum and then treated with BNL.IFN‐γ, an increase of IFN‐γ and decrease of TGF‐β1 were detected at 20 weeks postinfection compared to untreated S. japonicum‐infected mice. Immunohistochemical analysis showed that S. japonicum infection induced a marked increase of type I and III collagen synthesis. Whereas, 4 weeks after treatment with BNL.IFN‐γ, net synthesis rates of type I and III collagen were markedly decreased in the liver of infected mice. In addition, a decreased expression of TGF‐β1 and its receptor TGF‐βRII in the liver of BNL.IFN‐γ‐treated mice was also observed. Moreover, the decrease in TGF‐β1 and TGF‐βRII protein approximately paralleled the decrease in their mRNA expression, which was detected by RNA dot blotting. The data indicate that intrasplenic transplantation of IFN‐γ gene‐modified hepatocyte can be a candidate approach to treat hepatic fibrosis.